Gliknik's Series B Round

Gliknik raised a round of funding on October 08, 2012.

Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders. Gliknik's founders combine scientifi…

Articles about Gliknik's Series B Round: